Piedmont Research Center Offers Mouse and Rat Cryopreserved Hepatocytes

June 29, 2009 – As the cost of drug discovery becomes a growing concern, optimizing your preclinical spending is more important than ever. Including hepatocyte assays as part of your lead optimization program can serve as a cost-effective, early-stage in vitro model for drug metabolism. Applications include: metabolic profiling and stability, hepatotoxicity and bioavailability, among many others.

Piedmont Research Center, now part of the Charles River company, is pleased to announce the availability of mouse and rat cryopreserved hepatocytes isolated from animals that have been fully tested and housed in our AAALAC-accredited facility. All cells are suitable for both plated or suspension applications. 

Rely on rapid availability, consistency of yield and high cell viability to provide a clear advantage over other hepatocyte providers. In addition, we can provide hepatocytes isolated after in vivo dosing with your investigational agent to further enhance your research program.

For more information about our hepatocytes and the services offered through Piedmont, contact Piedmont at 919.462.8338 or visit www.piedmontrc.com. For information about the full portfolio of complementary discovery and research products and services offered by Charles River, contact us at 1.877.CRIVER.1 (1.877.274.8371) or askcharlesriver@crl.com or visit www.criver.com.